Savant Capital, LLC Biogen Inc. Transaction History

Savant Capital, LLC

$10.2 Billion
Q2 2024

A detailed history of Savant Capital, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 2,414 shares of BIIB stock, worth $487,145. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,414

Previous 2,535 4.77%

Holding current value

$487,145

Previous $546,000 2.38%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$190.52 - $236.72 $23,052 - $28,643	-121 Reduced 4.77%	2,414 $559,000
Q1 2024 May 03, 2024	BUY	$212.02 - $267.71 $35,195 - $44,439	166 Added 7.01%	2,535 $546,000
Q4 2023 Feb 05, 2024	BUY	$222.59 - $267.94 $34,724 - $41,798	156 Added 7.05%	2,369 $613,000
Q3 2023 Nov 06, 2023	BUY	$253.3 - $285.89 $156,032 - $176,108	616 Added 38.57%	2,213 $568,000
Q2 2023 Aug 04, 2023	BUY	$275.25 - $318.06 $113,953 - $131,676	414 Added 35.0%	1,597 $454,000
Q1 2023 May 02, 2023	BUY	$256.56 - $292.34 $38,997 - $44,435	152 Added 14.74%	1,183 $328,000
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $39,885 - $48,461	158 Added 18.1%	1,031 $285,000
Q3 2022 Oct 28, 2022	BUY	$194.69 - $268.46 $169,964 - $234,365	873 New	873 $233,000
Q2 2022 Jul 22, 2022	SELL	$187.54 - $223.02 $214,358 - $254,911	-1,143 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$193.77 - $244.14 $5,813 - $7,324	30 Added 2.7%	1,143 $241,000
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $28,661 - $36,834	-128 Reduced 10.31%	1,113 $267,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $23,771 - $31,000	84 Added 7.26%	1,241 $351,000
Q2 2021 Aug 04, 2021	SELL	$259.0 - $414.71 $3,626 - $5,805	-14 Reduced 1.2%	1,157 $401,000
Q1 2021 May 04, 2021	BUY	$242.95 - $284.63 $12,876 - $15,085	53 Added 4.74%	1,171 $328,000
Q4 2020 Feb 03, 2021	SELL	$236.26 - $355.63 $23,389 - $35,207	-99 Reduced 8.13%	1,118 $274,000
Q3 2020 Nov 04, 2020	BUY	$264.77 - $305.71 $37,862 - $43,716	143 Added 13.31%	1,217 $345,000
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $13,967 - $18,497	54 Added 5.29%	1,074 $287,000
Q1 2020 Apr 30, 2020	BUY	$268.85 - $341.04 $46,511 - $58,999	173 Added 20.43%	1,020 $323,000
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $186,390 - $257,547	847 New	847 $251,000
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $191,659 - $211,263	-874 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $13,368 - $16,932	-48 Reduced 5.21%	874 $263,000
Q3 2018 Oct 23, 2018	BUY	$293.51 - $383.83 $270,616 - $353,891	922 New	922 $326,000
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $234,858 - $279,901	-912 Closed	0 $0
Q1 2018 Apr 27, 2018	BUY	$260.13 - $367.91 $18,729 - $26,489	72 Added 8.57%	912 $250,000
Q4 2017 Jan 31, 2018	SELL	$307.64 - $344.58 $9,844 - $11,026	-32 Reduced 3.67%	840 $268,000
Q3 2017 Oct 31, 2017	BUY	$281.15 - $329.69 $245,162 - $287,489	872	872 $273,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Account

Savant Capital, LLC Biogen Inc. Transaction History